Evolus, Inc. | Business Contracts

Form of Performance Restricted Stock Unit Agreement (Filed With SEC on March 8, 2023)

Description of Securities (Filed With SEC on March 8, 2023)

License and Supply Agreement, dated as of September 30, 2013, by and between Daewoong Pharmaceutical Co., Ltd. and the Registrant (Filed With SEC on March 8, 2023)

Fourth Amendment to Supply Agreement, dated December 12, 2022, by and between Evolus, Inc. and Daewoong Pharmaceutical Co. Ltd (Filed With SEC on December 13, 2022)

Second Amendment to Loan Agreement, dated as of December 5, 2022, by and among Evolus, Inc. (as Borrower and a Credit Party), BioPharma Credit PLC (as Collateral Agent), BPCR... (Filed With SEC on December 8, 2022)

Employment Agreement, dated September 5, 2022, by and between Sandra Beaver and the Registrant (Filed With SEC on November 8, 2022)

Amended and Restated Employment Agreement, dated August 1, 2022, by and between Evolus, Inc. and Rui Avelar, M.D (Filed With SEC on August 2, 2022)

Separation Agreement and General Release of Claims, dated May 3, 2022, by and between Evolus, Inc. and Lauren Silvernail (Filed With SEC on August 2, 2022)

First Amendment to Loan Agreement, dated April 5, 2022, by and among Evolus, Inc. (as Borrower and a Credit Party), BioPharma Credit PLC (as Collateral Agent), BPCR Limited... (Filed With SEC on August 2, 2022)

Amendment to Employment Agreement, dated August 1, 2022, by and between Evolus, Inc. and David Moatazedi (Filed With SEC on August 2, 2022)

Separation Agreement and General Release of Claims, dated as of March 3, 202 (Filed With SEC on May 10, 2022)

Description of Securities (Filed With SEC on March 3, 2022)

Employment Agreement, dated February 25, 2021, by and between Crystal Muilenburg and the Registrant (Filed With SEC on March 3, 2022)

Loan Agreement, dated as of December 14, 2021, by and among Evolus, Inc. (as Borrower and a Credit Party), BioPharma Credit PLC (as Collateral Agent), BPCR Limited Partnership (as... (Filed With SEC on December 14, 2021)

Registration Rights Agreement, dated February 18, 2021, by and between Evolus, Inc. and Medytox, Inc (Filed With SEC on May 12, 2021)

Settlement and License Agreement, dated February 18, 2021, by and among Evolus, Inc., Allergan Limited, Allergan, Inc., Allergan Pharmaceuticals Ireland and Medytox, Inc (Filed With SEC on May 12, 2021)

Settlement and License Agreement, dated February 18, 2021, by and between Evolus, Inc. and Medytox, Inc (Filed With SEC on May 12, 2021)

Share Issuance Agreement, dated February 18, 2021, by and between Evolus Inc. and Medytox, Inc (Filed With SEC on May 12, 2021)

Confidential Settlement and Release Agreement, dated March 23, 2021, by and between Evolus, Inc. and Daewoong Pharmaceutical Co. Ltd (Filed With SEC on May 12, 2021)

Convertible Promissory Note Conversion Agreement, dated March 23, 2021, by and between Evolus, Inc. and Daewoong Pharmaceutical Co. Ltd (Filed With SEC on May 12, 2021)

Third Amendment to Supply Agreement, dated March 23, 2021, by and between Evolus, Inc. and Daewoong Pharmaceutical Co. Ltd (Filed With SEC on May 12, 2021)

Underwriting Agreement, dated (Filed With SEC on April 26, 2021)

Sales Agreement, dated March 26, 2021, by and between Evolus, Inc. and SVB Leerink LLC as Sales Agent (Filed With SEC on March 26, 2021)

Description of Securities (Filed With SEC on March 25, 2021)

Payoff Letter, dated January 4, 2021, from Oxford Finance LLC to Evolus, Inc (Filed With SEC on January 5, 2021)

Form of Convertible Promissory Note by and between Evolus, Inc. and Daewoong Pharmaceutical Co. Ltd (Filed With SEC on July 7, 2020)

Subordination Agreement. dated July 6, 2020, by and among Evolus, Inc., Oxford Finance, LLC and Daewoong Pharmaceutical Co. Ltd (Filed With SEC on July 7, 2020)

Convertible Promissory Note Purchase Agreement, dated July 6, 2020, by and between Evolus, Inc. and Daewoong Pharmaceutical Co. Ltd (Filed With SEC on July 7, 2020)

Description of Securities (Filed With SEC on February 25, 2020)

Form of RSU Award Agreement under 2017 Omnibus Incentive Plan (Updated 2020) (Filed With SEC on February 25, 2020)

Underwriting Agreement, dated November 6, 2019, by and between Evolus, Inc. and SVB Leerink LLC, Stifel, Nicolaus & Company, Incorporated and Cantor Fitzgerald & Co., as... (Filed With SEC on November 12, 2019)

First Amendment to Loan and Security Agreement dated as of July 18, 2019, by and between the Company and Oxford Finance, LLC (Filed With SEC on August 12, 2019)

Underwriting Agreement, dated as of May 15, 2019, among the Registrant, ALPHAEON Corporation and Morgan Stanley & Co. LLC (Filed With SEC on May 21, 2019)

Lease, dated as of May 15, 2019, between the Registrant and 520 Newport Center Drive LLC (Filed With SEC on May 21, 2019)

Loan and Security Agreement dated as of March 15, 2019, by and between the Company and Oxford Finance, LLC (Filed With SEC on May 1, 2019)

Employment Agreement, dated August 15, 2018, by and between Rui Avelar and the Registrant (Filed With SEC on March 20, 2019)

Sublease, dated as of November 7, 2018, by and between Acacia Research Corporation and the Registrant (Filed With SEC on March 20, 2019)

Separation Agreement and General Release of Claims, dated as of August 28, 2018, by and between J. Christopher Marmo and the Registrant (Filed With SEC on March 20, 2019)

Employment Agreement, dated August 15, 2018, by and between the Company and Rui Avelar, M.D (Filed With SEC on November 5, 2018)

Separation Agreement, dated August 17, 2018, by and among the Company, ALPHAEON Corporation, and J. Christopher Marmo, Ph.D (Filed With SEC on November 5, 2018)

Underwriting Agreement, dated July 18, 2018, among Evolus, Inc., Alphaeon Corporation, Cantor Fitzgerald & Co., and Mizuho Securities USA LLC (Filed With SEC on July 23, 2018)

Form of Underwriting Agreement (Filed With SEC on July 16, 2018)

Separation Agreement and General Release of Claims, dated as of May 10, 2018, by and between Murthy Simhambhatla and the Registrant (Filed With SEC on July 16, 2018)

Employment Agreement, dated as of May 6, 2018, by and between David Moatazedi and the Registrant (Filed With SEC on July 16, 2018)

Employment Agreement, dated as of May 29, 2018, by and between Lauren Silvernail and the Registrant (Filed With SEC on July 16, 2018)

Employment Agreement, dated as of June 18, 2018, by and between Michael Jafar and the Registrant (Filed With SEC on July 16, 2018)

Form of Underwriting Agreement (Filed With SEC on February 1, 2018)

Services Agreement, dated as of January 23, 2018, by and between ALPHAEON Corporation and the Registrant (Filed With SEC on January 25, 2018)

Employment Agreement, by and between Murthy Simhambhatla and the Registrant, to be effective in connection with the completion of this offering (Filed With SEC on January 25, 2018)

Transfer Letter, dated as of January 22, 2018, by and between Rui Avelar and the Registrant, to be effective in connection with the completion of this offering (Filed With SEC on January 25, 2018)

Form of Indemnification Agreement by and between the Registrant and its directors and officers (Filed With SEC on January 25, 2018)

Specimen certificate evidencing shares of common stock of the Registrant (Filed With SEC on January 25, 2018)

Amended and Restated Intercreditor Agreement, amended and restated as of April 19, 2017, by and among Longitude Venture Partners II, L.P., Dental Innovations BVBA, ALPHAEON... (Filed With SEC on January 9, 2018)

First Amendment to Amended and Restated Intercreditor Agreement, dated as of December 14, 2017, by and among Longitude Venture Partners II, L.P., Dental Innovations BVBA, ALPHAEON... (Filed With SEC on January 9, 2018)

Guaranty and Security Agreement, dated as of April 19, 2017, by and between Dental Innovations BVBA and the Registrant (Filed With SEC on January 9, 2018)

Amendment to Guaranty and Security Agreement, dated as of December 14, 2017, by and between Dental Innovations BVBA and the Registrant (Filed With SEC on January 9, 2018)

Guaranty and Security Agreement, dated as of April 19, 2017, by and between Longitude Venture Partners II, L.P. and the Registrant (Filed With SEC on January 9, 2018)

Amendment to Guaranty and Security Agreement, dated as of December 14, 2017, by and between Longitude Venture Partners II, L.P. and the Registrant (Filed With SEC on January 9, 2018)

Second Amendment to Stock Purchase Agreement, dated as of December 14, 2017, by and among SCH-AEON, LLC (f/k/a Strathspey Crown Holdings, LLC), ALPHAEON Corporation, the... (Filed With SEC on January 9, 2018)

Tax Indemnity Agreement, dated as of December 14, 2017, by and among the Registrant, J. Christopher Marmo, as the Contributors Representative and each of the individuals listed on... (Filed With SEC on January 9, 2018)

Exclusive Distribution and Supply Agreement, dated as of November 30, 2017, by and between Clarion Medical Technologies Inc. and the Registrant (Filed With SEC on January 9, 2018)

Therapeutic Option Letter Agreement, dated December 18, 2017, by and between ALPHAEON Corporation and the Registrant (Filed With SEC on January 9, 2018)

Subordination Agreement, dated as of December 14, 2017, by and among Dental Innovations BVBA, Longitude Venture Partners II, L.P., ALPHAEON Corporation, the Registrant and J.... (Filed With SEC on January 9, 2018)

Subordination Agreement, dated as of December 14, 2017, by and among Dental Innovations BVBA, Longitude Venture Partners II, L.P., ALPHAEON Corporation and SCH-AEON, LLC (formerly... (Filed With SEC on January 9, 2018)

Lease, dated February 5, 2015, by and between J. Carol Duncan and the Registrant (Filed With SEC on January 9, 2018)

Form of RSU Award Agreement under 2017 Omnibus Incentive Plan (Filed With SEC on January 9, 2018)

Form of Restricted Shares Award Agreement under 2017 Omnibus Incentive Plan (Filed With SEC on January 9, 2018)

Form of Dueling Option Award Agreement under 2017 Omnibus Incentive Plan (Filed With SEC on January 9, 2018)

Form of Option Award Agreement under 2017 Omnibus Incentive Plan (Filed With SEC on January 9, 2018)

2017 Omnibus Incentive Plan (Filed With SEC on January 9, 2018)

Second Amendment to License and Supply Agreement, dated as of July 15, 2014, by and between Daewoong Pharmaceutical Co., Ltd. and the Registrant (Filed With SEC on January 9, 2018)

First Amendment to License and Supply Agreement, dated as of February 26, 2014, by and between Daewoong Pharmaceutical Co., Ltd. and the Registrant (Filed With SEC on January 9, 2018)

License and Supply Agreement, dated as of September 30, 2013, by and between Daewoong Pharmaceutical Co., Ltd. and the Registrant (Filed With SEC on January 9, 2018)

Amendment to Stock Purchase Agreement, dated as of September 30, 2014, by and between Strathspey Crown Holdings, LLC and ALPHAEON Corporation (Filed With SEC on January 9, 2018)

Stock Purchase Agreement, dated as of September 30, 2014, by and between Strathspey Crown Holdings, LLC and ALPHAEON Corporation (Filed With SEC on January 9, 2018)

Stockholders Agreement, dated as of December 14, 2017, by and among ALPHAEON Corporation, Dental Innovations BVBA, Longitude Venture Partners II, L.P. and the Registrant (Filed With SEC on January 9, 2018)

Contribution Agreement, dated as of October 3, 2013, by and among Strathspey Crown Holdings, LLC, the Registrant, the Shareholders of the Registrant, and J. Christopher Marmo, as... (Filed With SEC on January 9, 2018)

Evolus, Inc. (77)